Cocrystal Pharma (COCP) Cash from Investing Activities (QoQ) (2010 - 2024)

Cocrystal Pharma (COCP) Cash from Investing Activities (QoQ) (2010 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Cocrystal Pharma 12.57 Mn 7.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 86.44%
Jun 30, 2023 68.89%
Mar 31, 2023 -275.00%
Dec 31, 2021 -100.00%
Sep 30, 2021 73.33%
Jun 30, 2021 40.00%
Mar 31, 2021 -2,400.00%
Dec 31, 2020 94.74%
Sep 30, 2020 85.04%
Jun 30, 2020 -36.56%
Mar 31, 2020 -9,200.00%
Dec 31, 2019 99.13%
Sep 30, 2019 -2,775.00%
Jun 30, 2019 84.00%
Mar 31, 2019 -66.67%
Dec 31, 2018 -87.50%
Mar 31, 2018 11,525.00%
Jun 30, 2017 42.42%
Mar 31, 2017 -194.29%
Dec 31, 2016 66.67%